Literature DB >> 21046125

Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages.

Sara L Coleman1, Young-Ki Park, Ji-Young Lee.   

Abstract

BACKGROUND: Adipocyte fatty acid binding protein (A-FABP) present in macrophages has been implicated in the integration of lipid metabolism and inflammatory response, contributing to development of insulin resistance and atherosclerosis. AIM OF THE STUDY: This study was conducted to test the hypothesis that the role of fatty acids in the inflammatory pathways is mediated through the modulation of A-FABP expression in macrophages.
METHODS: Murine RAW 264.7 macrophages were treated with inflammatory insults and fatty acids for quantitative real-time PCR and Western blot analysis. The cells were treated with trichostatin A (TSA), a histone deacetylase inhibitor, for elucidating mechanisms for the regulation of A-FABP expression by fatty acids. RNA interference (RNAi) to knock down A-FABP was utilized to assess its role in inflammatory gene expression.
RESULTS: When RAW 264.7 were incubated with lipopolysaccharides (LPS; 100 ng/ml) or 2.5 ng/ml of tumor necrosis factor α for 18 h, A-FABP mRNA and protein levels were drastically increased. Unsaturated fatty acids (100 μmol/l in complexed with BSA) such as palmitoleic acid, oleic acid, linoleic acid, linolenic acid, and eicosapentaenoic acid, significantly repressed the basal as well as LPS-induced A-FABP expression, whereas palmitic acid did not elicit the same effect. TSA increased A-FABP mRNA levels and abolished the repressive effect of linoleic acid on A-FABP expression in unstimulated and LPS-stimulated macrophages. Depletion of A-FABP expression by 70-80% using RNAi markedly decreased cyclooxygenase 2 mRNA abundance and potentiated the repression by linoleic acid.
CONCLUSION: Unsaturated fatty acids inhibited the basal as well as LPS-induced A-FABP expression. The mechanism may involve histone deacetylation and anti-inflammatory effect of unsaturated fatty acids may be at least in part attributed to their repression of A-FABP expression in RAW 264.7 macrophages.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21046125     DOI: 10.1007/s00394-010-0140-9

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  51 in total

1.  Genes modulated by histone acetylation as new effectors of butyrate activity.

Authors:  F Della Ragione; V Criniti; V Della Pietra; A Borriello; A Oliva; S Indaco; T Yamamoto; V Zappia
Journal:  FEBS Lett       Date:  2001-06-22       Impact factor: 4.124

2.  Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site.

Authors:  M Adams; M J Reginato; D Shao; M A Lazar; V K Chatterjee
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

3.  The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

Authors:  C Van Lint; S Emiliani; E Verdin
Journal:  Gene Expr       Date:  1996

4.  Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor.

Authors:  S K Lee; J H Kim; Y C Lee; J Cheong; J W Lee
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

5.  The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.

Authors:  P N Munster; T Troso-Sandoval; N Rosen; R Rifkind; P A Marks; V M Richon
Journal:  Cancer Res       Date:  2001-12-01       Impact factor: 12.701

6.  Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

Authors:  K T Uysal; L Scheja; S M Wiesbrock; S Bonner-Weir; G S Hotamisligil
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

7.  Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.

Authors:  E Hu; J B Kim; P Sarraf; B M Spiegelman
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

8.  Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos.

Authors:  R J Distel; H S Ro; B S Rosen; D L Groves; B M Spiegelman
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

9.  Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.

Authors:  Orina A Belton; Angela Duffy; Sinead Toomey; Desmond J Fitzgerald
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

10.  Common DNA binding site for Fos protein complexes and transcription factor AP-1.

Authors:  F J Rauscher; L C Sambucetti; T Curran; R J Distel; B M Spiegelman
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

View more
  10 in total

Review 1.  The Role of the Novel Lipokine Palmitoleic Acid in Health and Disease.

Authors:  María E Frigolet; Ruth Gutiérrez-Aguilar
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

Review 2.  Phenotypic modulation of macrophages in response to plaque lipids.

Authors:  Samantha Adamson; Norbert Leitinger
Journal:  Curr Opin Lipidol       Date:  2011-10       Impact factor: 4.776

Review 3.  Adipokines, adiposity, and atherosclerosis.

Authors:  Longhua Liu; Zunhan Shi; Xiaohui Ji; Wenqian Zhang; Jinwen Luan; Tarik Zahr; Li Qiang
Journal:  Cell Mol Life Sci       Date:  2022-05-03       Impact factor: 9.261

4.  Lipid chaperones and metabolic inflammation.

Authors:  Masato Furuhashi; Shutaro Ishimura; Hideki Ota; Tetsuji Miura
Journal:  Int J Inflam       Date:  2011-10-30

5.  Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia.

Authors:  Xiaoliang Liang; Kushagra Gupta; Joselyn Rojas Quintero; Manuela Cernadas; Lester Kobzik; Helen Christou; Gerald B Pier; Caroline A Owen; Sule Çataltepe
Journal:  FASEB J       Date:  2018-11-21       Impact factor: 5.834

Review 6.  Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.

Authors:  Masato Furuhashi; Shigeyuki Saitoh; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Clin Med Insights Cardiol       Date:  2015-02-02

7.  Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters.

Authors:  Masato Furuhashi; Shinya Hiramitsu; Tomohiro Mita; Akina Omori; Takahiro Fuseya; Shutaro Ishimura; Yuki Watanabe; Kyoko Hoshina; Megumi Matsumoto; Marenao Tanaka; Norihito Moniwa; Hideaki Yoshida; Junnichi Ishii; Tetsuji Miura
Journal:  Lipids Health Dis       Date:  2016-01-12       Impact factor: 3.876

Review 8.  Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.

Authors:  Masato Furuhashi
Journal:  J Atheroscler Thromb       Date:  2019-02-07       Impact factor: 4.928

9.  Serum adipocyte fatty acid-binding protein in the critically ill.

Authors:  Undurti N Das
Journal:  Crit Care       Date:  2013-03-06       Impact factor: 9.097

Review 10.  The Novel Perspectives of Adipokines on Brain Health.

Authors:  Thomas Ho-Yin Lee; Kenneth King-Yip Cheng; Ruby Lai-Chong Hoo; Parco Ming-Fai Siu; Suk-Yu Yau
Journal:  Int J Mol Sci       Date:  2019-11-11       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.